Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial.Haizhen Yang, Xuejun Zhu, Hongzhong Jin et al.|PubMed|2012Cited by 73